Valuation SOPHiA GENETICS SA Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Market Closed -
Börse Stuttgart
20:55:51 07/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.850 EUR | -1.44% |
|
-4.20% | +76.55% |
| 08-04 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
Company Valuation: SOPHiA GENETICS SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 900.4 | 132.3 | 306.8 | 204 | 316.8 | 688.7 | - | - |
| Change | - | -85.31% | 131.92% | -33.51% | 55.34% | 117.36% | - | - |
| Enterprise Value (EV) | 635.1 | -29.03 | 183.5 | 151.6 | 316.8 | 688.7 | 688.7 | 688.7 |
| Change | - | -104.57% | 732.16% | -17.4% | 109.03% | 117.36% | 0% | 0% |
| P/E | -10.6x | -1.51x | -3.86x | -3.23x | -3.99x | -8.62x | -12.9x | -22.3x |
| PBR | 3.27x | 0.66x | 2.03x | 2.13x | - | - | - | - |
| PEG | - | -0.67x | 0.4x | 0.1x | -0.2x | 0.4x | 0.4x | 0.5x |
| Capitalization / Revenue | 22.3x | 2.78x | 4.92x | 3.13x | 4.1x | 7.23x | 5.8x | 4.46x |
| EV / Revenue | 0x | -0x | 0x | 0x | 0x | 7.23x | 5.8x | 4.46x |
| EV / EBITDA | -0x | 0x | -0x | -0x | -0x | -21.8x | -33.9x | 275x |
| EV / EBIT | -0x | 0x | -0x | -0x | -0x | -10.4x | -14.6x | -29.6x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.33 | -1.36 | -1.22 | -0.95 | -1.17 | -0.938 | -0.626 | -0.3625 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 40.45 | 47.56 | 62.37 | 65.17 | 77.27 | 95.23 | 118.7 | 154.3 |
| EBITDA 1 | -67.88 | -82.25 | -66.49 | -57.97 | -41.5 | -31.53 | -20.3 | 2.5 |
| EBIT 1 | -71.49 | -87.82 | -74.83 | -66.57 | -70.91 | -66.1 | -47.2 | -23.28 |
| Net income 1 | -73.68 | -87.45 | -78.98 | -62.49 | -79 | -72.06 | -48.53 | -23.28 |
| Net Debt | -265.3 | -161.3 | -123.3 | -52.39 | - | - | - | - |
| Reference price 2 | 14.100 | 2.060 | 4.710 | 3.070 | 4.670 | 8.090 | 8.090 | 8.090 |
| Nbr of stocks (in thousands) | 63,858 | 64,211 | 65,132 | 66,439 | 67,847 | 85,128 | - | - |
| Announcement Date | 15/03/22 | 07/03/23 | 05/03/24 | 04/03/25 | 03/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 42.12x | 10.16x | 22.39x | -.--% | 44.54B | |
| 97.03x | 52.79x | 67.03x | 0.54% | 13.1B | |
| 75.23x | 12.87x | 51.87x | 0.55% | 5.85B | |
| -58.05x | 16.45x | -107.72x | - | 4.25B | |
| -7.03x | 62.88x | -7.13x | - | 2.1B | |
| 34.95x | - | - | -.--% | 1.57B | |
| -129.52x | - | - | - | 1.1B | |
| 6.94x | - | - | - | 1.02B | |
| Average | 7.71x | 31.03x | 5.29x | 0.27% | 9.19B | |
| Weighted average by Cap. | 44.14x | 20.35x | 24.42x | 0.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
- Valuation SOPHiA GENETICS SA
Select your edition
All financial news and data tailored to specific country editions
